Actavis CEO Says Health Law May Boost Generics Use

Feb. 15 (Bloomberg) -- Paul Bisaro, chief executive officer of Actavis Inc., talks about the impact of the U.S. Affordable Care Act on the pharmaceutical industry, so-called biosimilars, generic versions of biotechnology drugs, and the outlook for growth. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Fed Approves Emergency Lending Limits for Financial Firms
17:54 - Federal Reserve Chair Janet Yellen presides over a meeting of the Fed Board of Governors in Washington to discuss and vote on rules governing the central bank's ability to help failing financial firms. Under the Fed’s revised authority approved in the vote Monday, the central bank would only be able to save firms in a broad-based scenario, meaning it must help at least five entities at the same time. (Source: Bloomberg)
  • Inside the Business of Retail Returns
  • Dunkin' Brands CEO: All-Day Menu a Brand Strength
  • Looking Ahead to the ECB Rate Decision